Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Bioequivalence: Overview01:16

Bioequivalence: Overview

913
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
913

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Pregnancy, privacy, and procedural risk in dermatology.

Journal of the American Academy of Dermatology·2026
Same author

Alpelisib for TEK- and PIK3CA-Related Venous Malformations: A Systematic Review.

The Australasian journal of dermatology·2026
Same author

Autonomy vs nonmaleficence: Working out an isotretinoin dilemma.

Journal of the American Academy of Dermatology·2026
Same author

Infection Without Borders.

Journal of paediatrics and child health·2026
Same author

Effectiveness of a virtual hospital model of care for patients with low back pain presenting to emergency departments (Back@Home).

NPJ digital medicine·2026
Same author

Direct-to-consumer healthcare and its expanding role in the Australian healthcare system.

Internal medicine journal·2026

相关实验视频

Updated: May 29, 2025

An Orthotopic Resectional Mouse Model of Pancreatic Cancer
07:17

An Orthotopic Resectional Mouse Model of Pancreatic Cancer

Published on: September 24, 2020

10.3K

澳大利亚皮肤病学家的生物类似药.

Grace X Li1,2, Mona Marabani3, Deshan F Sebaratnam1,2

  • 1South West Sydney Clinical School, University of New South Wales, Liverpool, New South Wales, Australia.

The Australasian journal of dermatology
|February 5, 2025
PubMed
概括
此摘要是机器生成的。

生物类似药可以显著降低澳大利亚的医疗保健成本,特别是在慢性皮肤疾病的皮肤病学中. 克服临床医师教育和患者认知等障碍是成功采用和确保公平获取的关键.

关键词:
生物的生物的生物的生物.生物制剂是一种生物制剂.生物类似药物生物类似药物皮肤学 皮肤学经济 经济 经济 经济 经济可持续性 可持续性 可持续性

更多相关视频

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

38.8K
Novel Photoacoustic Microscopy and Optical Coherence Tomography Dual-modality Chorioretinal Imaging in Living Rabbit Eyes
09:20

Novel Photoacoustic Microscopy and Optical Coherence Tomography Dual-modality Chorioretinal Imaging in Living Rabbit Eyes

Published on: February 8, 2018

10.8K

相关实验视频

Last Updated: May 29, 2025

An Orthotopic Resectional Mouse Model of Pancreatic Cancer
07:17

An Orthotopic Resectional Mouse Model of Pancreatic Cancer

Published on: September 24, 2020

10.3K
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

38.8K
Novel Photoacoustic Microscopy and Optical Coherence Tomography Dual-modality Chorioretinal Imaging in Living Rabbit Eyes
09:20

Novel Photoacoustic Microscopy and Optical Coherence Tomography Dual-modality Chorioretinal Imaging in Living Rabbit Eyes

Published on: February 8, 2018

10.8K

科学领域:

  • 卫生经济学 卫生经济学
  • 药物经济学 药物经济学
  • 皮肤病学 皮肤病学

背景情况:

  • 生物类似药在澳大利亚医疗保健系统中为降低成本提供了重大机会.
  • 生物药物对于治疗慢性皮肤病至关重要,这代表了潜在节省的重要领域.
  • 患者和临床医生的因素,包括教育和感知,目前阻碍生物类似药的吸收.

研究的目的:

  • 评估澳大利亚生物类似药的经济影响.
  • 在临床实践中识别生物类似药物采用的障碍.
  • 评估生物类似药在制药福利计划可持续性中的作用.

主要方法:

  • 经济建模以估计成本节约.
  • 关于临床医生和患者感知的文献综述.
  • 对当前生物类药物吸收数据的分析.

主要成果:

  • 通过生物仿制药的使用,可以实现大幅度的成本节约,特别是在慢性皮肤疾病的长期患者护理中.
  • 采用的主要障碍包括临床医生的教育不足,对安全性和疗效的担忧,以及患者的负面看法.
  • 增加生物类似药的可用性支持制药福利计划和公平的医疗保健准入.

结论:

  • 生物仿制药为澳大利亚医疗保健系统提供了显著的经济效益,特别是在皮肤病学领域.
  • 解决与教育和感知有关的障碍对于最大限度地利用生物类似药物至关重要.
  • 广泛采用生物类似药对制药效益的长期可持续性和澳大利亚各地的公平医疗保健准入至关重要.